NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jun 30 04:00PM ET
19.37
Dollar change
+0.11
Percentage change
0.57
%
IndexRUT P/E- EPS (ttm)-2.09 Insider Own31.20% Shs Outstand11.25M Perf Week2.00%
Market Cap209.35M Forward P/E- EPS next Y-2.38 Insider Trans0.00% Shs Float7.44M Perf Month-9.23%
Enterprise Value178.19M PEG- EPS next Q-0.57 Inst Own32.16% Short Float12.32% Perf Quarter21.44%
Income-21.22M P/S10.90 EPS this Y33.66% Inst Trans-3.05% Short Ratio12.93 Perf Half Y8.27%
Sales19.21M P/B6.97 EPS next Y-18.49% ROA-32.30% Short Interest0.92M Perf YTD8.82%
Book/sh2.78 P/C5.47 EPS next 5Y12.32% ROE-77.92% 52W High24.00 -19.29% Perf Year27.27%
Cash/sh3.54 P/FCF- EPS past 3/5Y4.48% - ROIC-56.30% 52W Low14.14 36.99% Perf 3Y78.53%
Dividend Est.- EV/EBITDA- Sales past 3/5Y-5.24% -8.65% Gross Margin14.39% Volatility2.84% 3.25% Perf 5Y2.87%
Dividend TTM- EV/Sales9.28 EPS Y/Y TTM-51.08% Oper. Margin-108.62% ATR (14)0.71 Perf 10Y-59.66%
Dividend Ex-Date- Quick Ratio1.99 Sales Y/Y TTM-3.21% Profit Margin-110.45% RSI (14)43.03 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio2.15 EPS Q/Q93.62% SMA20-5.00% Beta0.33 Target Price30.67
Payout- Debt/Eq0.23 Sales Q/Q-20.33% SMA50-0.94% Rel Volume0.66 Prev Close19.26
Employees111 LT Debt/Eq0.21 EarningsMay 21 BMO SMA2007.88% Avg Volume70.88K Price19.37
IPOMar 20, 2014 Option/ShortYes / Yes EPS/Sales Surpr.89.42% -23.91% Trades Volume46,749 Change0.57%
Date Action Analyst Rating Change Price Target Change
Jun-02-25Resumed Oppenheimer Outperform $34
May-02-25Initiated Alliance Global Partners Buy $25
Feb-28-25Initiated Craig Hallum Buy $39
Jul-16-24Reiterated Maxim Group Buy $25 → $30
Dec-22-22Initiated Maxim Group Buy $11
Jul-18-22Resumed Oppenheimer Outperform $7
Sep-23-20Initiated BTIG Research Buy $6
Nov-28-16Initiated Aegis Capital Buy $11
Aug-17-16Initiated Wells Fargo Outperform
Apr-16-14Initiated Oppenheimer Outperform $25
May-22-25 03:03AM
May-21-25 08:10AM
07:08AM
07:00AM
May-20-25 09:21AM
05:45PM Loading…
May-15-25 05:45PM
May-14-25 08:25PM
May-13-25 05:40PM
07:30AM
May-12-25 05:15PM
May-08-25 06:05PM
May-05-25 08:00AM
Apr-28-25 08:00AM
Mar-21-25 06:31PM
Mar-20-25 03:01AM
12:10PM Loading…
Mar-19-25 12:10PM
08:10AM
07:17AM
07:00AM
Mar-03-25 08:00AM
Feb-25-25 08:00AM
Feb-24-25 08:00AM
Feb-13-25 10:27AM
Feb-12-25 07:00AM
Feb-04-25 08:00AM
Jan-27-25 06:32AM
Jan-09-25 08:28AM
Dec-17-24 08:00AM
07:27AM
Nov-27-24 02:02AM
08:15AM Loading…
Nov-26-24 08:15AM
07:10AM
07:00AM
Nov-25-24 07:02AM
Nov-12-24 08:00AM
Oct-23-24 07:01PM
Oct-10-24 07:00AM
Oct-08-24 08:00AM
Sep-03-24 08:00AM
Aug-16-24 10:33AM
Aug-15-24 04:15PM
Aug-14-24 08:15AM
07:18AM
07:00AM
Aug-07-24 10:00AM
Aug-05-24 07:30AM
Aug-02-24 08:00AM
Jul-31-24 09:55AM
Jul-30-24 07:13AM
Jul-29-24 08:00AM
Jul-16-24 07:30AM
Jul-15-24 07:38AM
07:38AM
07:00AM
May-29-24 02:40PM
11:53AM
08:15AM
07:12AM
07:00AM
May-22-24 08:00AM
Apr-25-24 08:00AM
Apr-17-24 07:24AM
Mar-25-24 09:55AM
08:50AM
Mar-21-24 11:54AM
08:25AM
07:25AM
07:00AM
Mar-14-24 08:00AM
Mar-06-24 08:46AM
Feb-12-24 07:00AM
Feb-05-24 08:00AM
Jan-15-24 09:55AM
Jan-09-24 06:21PM
08:48AM
07:00AM
Dec-28-23 07:00AM
Dec-21-23 08:00AM
Dec-13-23 09:55AM
Nov-27-23 09:55AM
Nov-21-23 07:12AM
07:02AM
07:00AM
Nov-14-23 08:02AM
Nov-13-23 07:00AM
Nov-08-23 07:00AM
Oct-11-23 06:00AM
Oct-09-23 07:34AM
Oct-03-23 01:20PM
Sep-29-23 08:00AM
Sep-26-23 07:00AM
Sep-21-23 06:00AM
Sep-11-23 08:00AM
Sep-05-23 08:00AM
Aug-15-23 05:15PM
04:11PM
04:03PM
04:02PM
04:01PM
Aug-07-23 08:00AM
MediWound Ltd. is a biopharmaceutical company, which engages in the development, manufacture, and commercialization of products to address needs in the fields of severe burns, chronic wounds, and other hard-to-heal wounds. Its product NexoBrid, is an orphan biologic for eschar removal in severe burns. The company was founded by Lior Rosenberg and Marian Gorecki in January 2000 and is headquartered in Yavne, Israel.